OTCMKTS:MYDX

MyDx Stock Forecast, Price & News

0.0002
0.00 (-50.00 %)
(As of 08/2/2021 03:59 PM ET)
Add
Compare
Today's Range
0.00
0.00
50-Day Range N/A
52-Week Range
0.00
0.00
Volume164.62 million shs
Average Volume119.42 million shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A
30 days | 90 days | 365 days | Advanced Chart
Receive MYDX News and Ratings via Email

Sign-up to receive the latest news and ratings for MyDx and its competitors with MarketBeat's FREE daily newsletter.


MyDx logo

About MyDx

MyDx, Inc. is a science and technology company, which engages in the development and deployment of products and services in the areas of consumer products, data analytics, biopharmaceutical, and software as a service. Its product, MyDx, is a patented multiuse hand-held chemical analyzer designed to help consumers and professional test for pesticides in food, chemicals in water, toxins in the air, and safety and potency of cannabis samples. The company was founded by Daniel Rida Yazbeck on December 20, 2012 and is headquartered in San Diego, CA.

Headlines

No headlines for this company have been tracked by MarketBeat.com

Industry, Sector and Symbol

Sales & Book Value

Profitability

Debt

Price-To-Earnings

Miscellaneous


MarketRank

Overall MarketRank

0.00 out of 5 stars

Computer And Technology Sector

1537th out of 1,651 stocks

Scientific & Technical Instruments Industry

16th out of 17 stocks

Analyst Opinion: 0.0Community Rank: 0.0Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -
speech bubbles
speech bubbles











MyDx (OTCMKTS:MYDX) Frequently Asked Questions

What stocks does MarketBeat like better than MyDx?

Wall Street analysts have given MyDx a "N/A" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but MyDx wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

Who are MyDx's key executives?

MyDx's management team includes the following people:
  • Daniel Rida Yazbeck, Chairman, Chief Executive & Financial Officer
  • Nicholas Hadler, Vice President-Operations

Who are some of MyDx's key competitors?

What is MyDx's stock symbol?

MyDx trades on the OTCMKTS under the ticker symbol "MYDX."

How do I buy shares of MyDx?

Shares of MYDX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is MyDx's stock price today?

One share of MYDX stock can currently be purchased for approximately 0.00.

What is MyDx's official website?

The official website for MyDx is www.mydxlife.com.

How can I contact MyDx?

The company can be reached via phone at (800) 814-4550.


This page was last updated on 8/3/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.